These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32997402)

  • 21. Difference in time-course of improvement in asthma control measures between budesonide and budesonide/formoterol.
    Matsunaga K; Kawabata H; Hirano T; Sugiura H; Minakata Y; Ichinose M
    Pulm Pharmacol Ther; 2013 Apr; 26(2):189-94. PubMed ID: 23123925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
    MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS; Cates CJ; Ducharme FM
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study.
    Bjermer L; Lemiere C; Maspero J; Weiss S; Zangrilli J; Germinaro M
    Chest; 2016 Oct; 150(4):789-798. PubMed ID: 27056586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial.
    Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A
    Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma.
    van der Molen T; Postma DS; Schreurs AJ; Bosveld HE; Sears MR; Meyboom de Jong B
    Qual Life Res; 1997 May; 6(4):353-61. PubMed ID: 9248317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ducharme FM; Lasserson TJ; Cates CJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of add-on montelukast on airway hyperresponsiveness in patients with well-controlled asthma - a pilot study.
    Kononowa N; Michel S; Miedinger D; Pichler CE; Chhajed PN; Helbling A; Leuppi JD
    J Drug Assess; 2013; 2(1):49-57. PubMed ID: 27536437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid.
    Walters EH; Gibson PG; Lasserson TJ; Walters JA
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001385. PubMed ID: 17253458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
    Holimon TD; Chafin CC; Self TH
    Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459.
    Pettipher R; Hunter MG; Perkins CM; Collins LP; Lewis T; Baillet M; Steiner J; Bell J; Payton MA
    Allergy; 2014 Sep; 69(9):1223-32. PubMed ID: 24866478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study.
    Brusselle G; Michils A; Louis R; Dupont L; Van de Maele B; Delobbe A; Pilette C; Lee CS; Gurdain S; Vancayzeele S; Lecomte P; Hermans C; MacDonald K; Song M; Abraham I
    Respir Med; 2009 Nov; 103(11):1633-42. PubMed ID: 19619998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chest tightness is relieved with the use of asthma drugs except bronchodilators.
    Taniguchi H; Nakanishi Y; Tsuda T; Masaki Y; Furuse H; Suzuki K; Ishizawa S; Muto A; Shimizu M; Ichikawa T; Miyazawa H
    J Asthma; 2019 Nov; 56(11):1182-1192. PubMed ID: 30426824
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of inhaled once-daily low-dose indacaterol acetate/mometasone furoate in patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings.
    Kornmann O; Mucsi J; Kolosa N; Bandelli L; Sen B; Satlin LC; D'Andrea P
    Respir Med; 2020 Jan; 161():105809. PubMed ID: 32056721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients.
    Werner CU; Linde K; Schäffner J; Storr C; Schneider A
    NPJ Prim Care Respir Med; 2017 Dec; 27(1):64. PubMed ID: 29222436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.
    Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q
    Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled long acting beta agonists for stable chronic asthma.
    Walters EH; Walters JA; Gibson MD
    Cochrane Database Syst Rev; 2003; (4):CD001385. PubMed ID: 14583933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial.
    Brusselle GG; Vanderstichele C; Jordens P; Deman R; Slabbynck H; Ringoet V; Verleden G; Demedts IK; Verhamme K; Delporte A; Demeyere B; Claeys G; Boelens J; Padalko E; Verschakelen J; Van Maele G; Deschepper E; Joos GF
    Thorax; 2013 Apr; 68(4):322-9. PubMed ID: 23291349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asthma control during the year after bronchial thermoplasty.
    Cox G; Thomson NC; Rubin AS; Niven RM; Corris PA; Siersted HC; Olivenstein R; Pavord ID; McCormack D; Chaudhuri R; Miller JD; Laviolette M;
    N Engl J Med; 2007 Mar; 356(13):1327-37. PubMed ID: 17392302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.